Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis
MetadataShow full item record
AuthorMoran Sánchez, Julia; Santisteban Espejo, Antonio Leopoldo; Martín Piedra, Miguel Ángel; Pérez Requena, José; García Rojo, Marcial
Artificial intelligenceHematopathologyLymphoid neoplasmsDigital image analysisMachine Learning
Moran-Sanchez, J.; Santisteban-Espejo, A.; Martin-Piedra, M.A.; Perez-Requena, J.; GarciaRojo, M. Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis. Biomolecules 2021, 11, 793. https://doi.org/10.3390/ biom11060793
SponsorshipAndalusia Health System - RH-0145-2020; EU FEDER ITI Grant for Cadiz Province PI-0032-2017
Genomic analysis and digitalization of medical records have led to a big data scenario within hematopathology. Artificial intelligence and machine learning tools are increasingly used to integrate clinical, histopathological, and genomic data in lymphoid neoplasms. In this study, we identified global trends, cognitive, and social framework of this field from 1990 to 2020. Metadata were obtained from the Clarivate Analytics Web of Science database in January 2021. A total of 525 documents were assessed by document type, research areas, source titles, organizations, and countries. SciMAT and VOSviewer package were used to perform scientific mapping analysis. Geographical distribution showed the USA and People’s Republic of China as the most productive countries, reporting up to 190 (36.19%) of all documents. A third-degree polynomic equation predicts that future global production in this area will be three-fold the current number, near 2031. Thematically, current research is focused on the integration of digital image analysis and genomic sequencing in Non-Hodgkin lymphomas, prediction of chemotherapy response and validation of new prognostic models. These findings can serve pathology departments to depict future clinical and research avenues, but also, public institutions and administrations to promote synergies and optimize funding allocation.